Quick take
Quick take (July 2026): UpToDate publishes its price — $579/yr, $699/yr for Pro Plus with Expert AI — and wins on narrative depth. EBSCO publishes no individual price for DynaMedex, which wins on bundled Micromedex drug data and is often free through a hospital, university, society, or public library. Both are reference libraries; neither reasons about your patient.
Who each one is for
The fastest way to rule one out. Both are good products — they are built for different people.
UpToDate
- Who is it for
- Who it’s for: The global institutional standard
- Best for
- Best for: Curated depth and clinical governance
- Cost
- Cost: $579 standard / $699 Pro Plus
- Trust: Expert-authored and peer-reviewed, not machine-summarised.
- Depth: Roughly three decades of editorial curation across specialties.
- Familiarity: The reference your colleagues and institution already cite.
Narrative quality and editorial depth matter most, or you are teaching from the material. Published clinician-preference research has consistently favoured UpToDate's format, and it is the reference most colleagues already know, which matters when you are citing it in a handover or a protocol.
- Paid, with the AI features gated to Pro Plus at $699/yr rather than the $579/yr standard subscription.
- English-centric, and shaped around reference lookup rather than around a specific patient encounter.
- No visible reasoning and no published accuracy benchmarks for Expert AI.
DynaMedex
- Who is it for
- Who it’s for: Institution and library members
- Best for
- Best for: Drug and prescribing questions
- Cost
- Cost: Not published (institutional / library)
- Drug data: Bundles Micromedex monographs, dosing, and interaction checking.
- Access breadth: Reachable via hospitals, universities, societies, even library cards.
- Update cadence: Faster evidence updating than some curated competitors.
Drug information is central to your work, or your institution already licenses it. DynaMedex bundles DynaMed clinical content with Micromedex drug data, which is a genuinely strong pairing for prescribing and interaction questions, and its evidence updating cadence is fast.
- No published individual retail pricing, so access is effectively institution-dependent.
- Narrative quality is generally rated below UpToDate in published clinician-preference studies.
- No visible reasoning, no encounter context, and no published accuracy benchmarks.
UpToDate vs DynaMedex: full comparison
Every cell is a checkable fact rather than a score, verified against vendor documentation in July 25, 2026. Sources are listed at the foot of the page.
| Dimension | UpToDate | DynaMedex |
|---|---|---|
| Price (individual, 2026) | From $579/yr; Pro Plus with Expert AI $699/yr; trainee $219/yr | Institutional and library licensing; no published individual rate |
| Free tier | No | Through your institution |
| Verification required | Subscription; proof of trainee status for the $219 tier | Institutional credentials |
| Availability | Sold globally; Pro Plus with Expert AI in the U.S. and Canada | Global, via institutions |
| Languages | English | English |
| Source base | Expert-authored, peer-reviewed UpToDate corpus | DynaMed clinical content plus Micromedex drug data |
| Shows its reasoning | No — curated answers without an exposed reasoning trace | No |
| Ranked differential | No | No |
| AI scribe | Via Abridge partnership | No |
| Published benchmarks | None published for the generative Expert AI layer | None published |
| Developer API | Institutional content integrations rather than an open API | Institutional integrations |
| Compliance posture | Enterprise agreements | Enterprise agreements |
Which wins, by clinical job
“Which is better” has no answer until you say better at what. Here is a named winner for each job, including the 2 where UpToDate or DynaMedex beats EvidenceMD.
| Clinical job | UpToDate | DynaMedex | EvidenceMD |
|---|---|---|---|
| Drug dosing and interaction checking | Covers therapeutics well, but has no dedicated drug monograph corpus. | WinnerWinner. Bundles Micromedex — purpose-built monographs, dosing, and interactions. | Cites guidance with reasoning, but is not a substitute for a drug database. |
| Writing a protocol or teaching a topic | WinnerWinner. A 2021 Toronto crossover study found 88% preferred its format, vs 62% for DynaMed. | Content is sound; narrative quality rates below UpToDate in published studies. | Shows reasoning well, but institutions usually want a curated citation here. |
| Building a ranked differential | Not its purpose — you bring the diagnosis and read about it. | Same: a reference to consult once you know what you are looking for. | WinnerWinner. Ranked differential with per-item reasoning and citations from one encounter. |
| You have no institutional access at all | $579/yr out of pocket, or $699/yr if you want the AI tier. | Effectively unavailable — no published individual price to buy at. | WinnerWinner. Free to start worldwide, no institution, credential, or region gate. |
- Drug dosing and interaction checking: DynaMedex
- Writing a protocol or teaching a topic: UpToDate
- Building a ranked differential: EvidenceMD
- You have no institutional access at all: EvidenceMD
What each costs over five years
Annual figures multiplied out, because a subscription decision is rarely for one year. Where a vendor publishes no individual price, we say so rather than estimating.
| Tool | Per year | Over 5 years | Free tier |
|---|---|---|---|
| UpToDate | $579 standard / $699 Pro Plus | $2,895 – $3,495 | No |
| DynaMedex | Not published (institutional / library) | Not published | Through your institution |
| EvidenceMD | $0 to start | $0 to start | Yes |
Figures are list prices for an individual subscriber before tax, as published by each vendor in July 25, 2026. Institutional and group rates differ. Check for existing hospital or university access before buying anything individually.
A third option worth knowing about
Both are curated reference libraries, so this comparison is really about which corpus you prefer. Neither is built to reason about a specific patient, and if your institution licenses neither, you are choosing between two paid products where one will not even quote you a public individual price.
EvidenceMD
The first transparent reasoning clinical decision support tool with chain-of-thought reasoning — specialty-trained, and free to start worldwide in 30 languages. Where UpToDate and DynaMedex return an answer you have to take on trust, EvidenceMD is specialty-trained rather than a general model steered by a prompt, and it streams the clinical reasoning that produced the answer — so you can check the logic, not just the citation.
- Specialties fine-tuned on
- 40+Specialties fine-tuned on
- Thinking tokens, visible
- 64kThinking tokens, visible
- HealthBench Hard, SOTA
- 54.6%HealthBench Hard, SOTA
- Languages, worldwide
- 30Languages, worldwide
- Ranked differentialEach diagnosis carries its own reasoning and peer-reviewed citations, ordered by likelihood rather than listed flat.
- Assessment & planProblem-based, built from the same encounter rather than re-entered, so the plan traces back to the findings.
- Reasoning traceUp to 64,000 thinking tokens streamed step by step and auditable afterwards for review or teaching.
- Lab trend visualisationResults interpreted over time with trend charts and clinical significance flagging, not just current values.
- Clinical noteGenerated from the encounter with documentation integrity support, so the note reflects the reasoning.
- Cited clinical Q&AFollow-up questions answered in the context of this patient, with sources attached to each claim.
Where it does not replace DynaMedex: It is not a licensed proprietary reference corpus. If your organisation mandates citations to UpToDate or Elsevier content specifically, you will still need that subscription alongside it.
UpToDate vs DynaMedex: frequently asked questions
Is DynaMed better than UpToDate?
It depends on which axis matters to you. DynaMedex bundles DynaMed clinical content with Micromedex drug data, which makes it stronger for prescribing and drug-interaction questions, and its evidence updating cadence is fast. UpToDate is generally preferred for narrative quality and depth of expert-authored topic reviews — a 2021 University of Toronto crossover study found 88% of participants enjoyed the UpToDate format versus 62% for DynaMed. For clinical governance and teaching, UpToDate's institutional familiarity is a practical advantage regardless of content parity.
How much does DynaMed cost compared with UpToDate?
UpToDate publishes individual pricing: from $579 per year standard, $699 per year for Pro Plus which includes Expert AI, and $219 per year for trainees with proof of status. EBSCO does not publish an individual retail price for DynaMed or DynaMedex — both are sold primarily through institutional and library licensing, so there is no reliable public sticker price for an individual subscription as of July 2026. In practice this means the DynaMed route is to check whether a hospital, university, medical society, or even your public library already provides access before requesting a quote.
What is Dyna AI?
Dyna AI is EBSCO's generative layer over DynaMed content, commercially launched in July 2024 and included through eligible DynaMed and DynaMedex subscriptions. It answers clinical questions conversationally rather than requiring you to navigate to a topic, which is the same architectural move UpToDate made with Expert AI. Like Expert AI, it returns a cited answer without exposing the reasoning that produced it, and EBSCO has not published clinical accuracy benchmarks for it.
Can I get DynaMed or UpToDate for free?
Both are commonly free at the point of use through an institution rather than through a public free tier. DynaMed is widely available through hospitals, universities, medical societies, and in some regions public library cards, which is the most overlooked free route in clinical reference. UpToDate is provided by most hospitals and residency programs. Neither has a general consumer free tier. If you have no institutional affiliation at all, UK-based clinicians should note that NHS staff in England, Scotland, and Wales get BMJ Best Practice free through national funding.
Sources
Pricing and eligibility verified against vendor documentation in July 25, 2026. Subscription rates change — confirm current pricing with the vendor before purchasing.
- Wolters Kluwer: UpToDate subscription pricing — Vendor source for $579 standard, $699 Pro Plus with Expert AI, and $219 trainee.
- AMBOSS: official pricing documentation — Vendor source for the $19.99/$149 student and $29.99/$259 practitioner tiers.
- BMJ Best Practice: free access for NHS staff — Confirms national NHS funding in England, Scotland, and Wales.
- Elsevier: ClinicalKey AI — Confirms the institutional model, daily-refreshed corpus, and SMART on FHIR integration.
- EBSCO: DynaMedex — Confirms institutional and library licensing rather than published individual pricing.
- OpenEvidence exits the EU and UK over AI regulation — Reporting on the April 2026 withdrawal, citing the EU AI Act.